BrainsWay
BWAY | NASDAQ
$9.39
-$0.72 (-7.12%)
At close: Nov 16, 2026, 4:00 PM ET
$9.39
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-7.12%
(1D)No price chart data available for 1D timeframe.
Rating
70.8
Fundamentals Excellent
Market Sentiment Neutral
Moat Narrow
Sector Rank #50/1021 (Top 5%)
Key Statistics
Market Data
Market Cap $368.3M
1D Range
9.27 9.69
52W Range
7.25 17.17
Valuation (TTM)
PE 18.78
PB 4.48
EV/EBITDA 25.08
Valuation (NTM)
Forward PE 34.86
Forward PEG -0.39
Price Target $19.50
Cash Flow
FCF Yield 3.2%
SBC Adj. FCF Yield 3.0%
SBC Impact -5.3%
Margins
Gross Margin 76.0%
Operating Margin 13.6%
FCF Margin 17.8%
Growth (CAGR)
Revenue 3Y | 5Y 31.5% |
18.3%
Dil EPS 3Y | 5Y 90.5% |
645.7%
FCF 3Y | 5Y 23.7% |
112.9%
Returns
ROA 8.0%
ROE 13.1%
ROIC 9.3%
Financial Health
Net Cash
$63.18M
Current Ratio 2.89
Interest Coverage 3.90
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
BrainsWay Ltd. develops and distributes non-invasive neurostimulation therapies that address a broad spectrum of mental health and neurological conditions. The company operates globally, with a presen...
Sector Healthcare
Industry Medical - Specialties
Employees 129
IPO Date Apr 17, 2019
Website www.brainsway.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 10, 2026
EPS
$0.1
Miss -16.67%
YoY:
+150.00% REV
$18.15M
Beat +1.96%
YoY:
+34.30%Next Earnings
Mar 10, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
3
Consensus
Buy
Price Target
$19.50
Upside
+107.67%
Buy (3)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove BWAY